Celltrion Healthcare, Current Stock Price -1.41%... 'Significant Operating Profit Improvement in 2020 is Positive'

As of 12:33 PM on the 22nd, Celltrion Healthcare is trading at 90,700 KRW, down 1.41% from the previous day. The trading volume is 751,796 shares, which is about 48.18% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

On May 21, researcher Lee Dal-mi from SK Securities stated, "Although performance was weak in 2018 due to intensified competition among biosimilars and price declines of Remsima IV, a turnaround was achieved in 2019. In 2020, strong growth in performance is expected due to continuous new product launches. In particular, concerns about price declines and price fluctuations of Remsima IV, which were previously worrisome, have been conservatively estimated, so significant price changes are unlikely." The target price for Celltrion Healthcare was set at 110,000 KRW.

Over the past five days, individual investors have net purchased 646,620 shares of Celltrion Healthcare, while foreign investors and institutions have net purchased 13,800 shares and net sold 682,719 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.